In multiple studies conducted in rheumatoid arthritis (RA) patients, the TNF blocking strategy has been associated with an increase of biological markers indicating bone formation and a decrease of those illustrating bone resorption [48–50]. Here, TNF is linked to rheumatoid arthritis.